Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-06 4:01 pm Purchase | 2022-08-25 | 13G | Generation Bio Co. GBIO | PFM Health Sciences, LP | 3,013,712 5.100% | 3,013,712 (New Position) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 8,647,121 15.100% | 2,303,511 (+36.31%) | Filing History |
| 2022-02-11 5:06 pm Sale | 2021-12-31 | 13G | Generation Bio Co. GBIO | Atlas Venture Fund X L.P. | 7,111,939 12.500% | -3,000,000 (-29.67%) | Filing History |
| 2022-02-11 4:44 pm Purchase | 2021-12-31 | 13G | Generation Bio Co. GBIO | BB BIOTECH AG | 3,853,180 6.800% | 1,460,000 (+61.01%) | Filing History |
| 2022-02-11 06:33 am Unchanged | 2021-12-31 | 13G | Generation Bio Co. GBIO | ARTAL INTERNATIONAL SA | 2,814,191 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Generation Bio Co. GBIO | The Vanguard Group | 3,594,461 6.320% | 3,594,461 (New Position) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Generation Bio Co. GBIO | FMR LLC | 8,536,462 14.999% | 1,355,598 (+18.88%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Generation Bio Co. GBIO | BLACKROCK INC BLK | 3,167,656 5.600% | 3,167,656 (New Position) | Filing History |
| 2022-02-03 09:23 am Purchase | 2021-12-31 | 13G | Generation Bio Co. GBIO | FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 6.200% | 229,500 (+7.02%) | Filing History |
| 2021-02-16 5:28 pm Purchase | 2020-12-31 | 13G | Generation Bio Co. GBIO | Atlas Venture Fund X L.P. | 10,111,939 21.700% | 10,111,939 (New Position) | Filing History |
| 2021-02-12 8:59 pm Unchanged | 2020-12-31 | 13G | Generation Bio Co. GBIO | ARTAL INTERNATIONAL SA | 2,814,191 6.000% | 0 (Unchanged) | Filing History |
| 2021-02-10 12:15 pm Purchase | 2021-01-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 6,343,610 11.300% | 1,949,426 (+44.36%) | Filing History |
| 2021-02-10 12:15 pm Purchase | 2020-12-31 | 13G | Generation Bio Co. GBIO | T. Rowe Price Associates, Inc. | 4,394,184 9.400% | 4,394,184 (New Position) | Filing History |
| 2021-02-08 10:23 am Sale | 2021-02-05 | 13G | Generation Bio Co. GBIO | FMR LLC | 7,180,864 15.437% | -193,006 (-2.62%) | Filing History |
| 2021-01-15 1:17 pm Purchase | 2021-01-07 | 13G | Generation Bio Co. GBIO | FARALLON CAPITAL MANAGEMENT LLC | 3,270,500 6.000% | 3,270,500 (New Position) | Filing History |
| 2021-01-08 09:52 am Purchase | 2020-12-31 | 13G | Generation Bio Co. GBIO | BB BIOTECH AG | 2,393,180 5.100% | 2,393,180 (New Position) | Filing History |
| 2020-08-24 10:06 am Purchase | 2020-06-30 | 13G | Generation Bio Co. GBIO | FMR LLC | 7,373,870 15.956% | 441,865 (+6.37%) | Filing History |
| 2020-07-10 11:38 am Purchase | 2020-07-09 | 13G | Generation Bio Co. GBIO | FMR LLC | 6,932,005 14.999% | 6,932,005 (New Position) | Filing History |
| 2020-06-26 12:12 pm Purchase | 2020-06-16 | 13G | Generation Bio Co. GBIO | ARTAL INTERNATIONAL SA | 2,814,191 6.300% | 2,814,191 (New Position) | Filing History |
| 2020-06-25 6:07 pm Purchase | 2020-06-16 | 13G | Generation Bio Co. GBIO | Zone Healthcare Holdings, LLC | 2,118,819 4.700% | 2,118,819 (New Position) | Filing History |